Home/Filings/4/0001213900-17-006306
4//SEC Filing

KBL MERGER CORP. IV 4

Accession 0001213900-17-006306

$ETHZCIK 0001690080operating

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:00 PM ET

Size

7.5 KB

Accession

0001213900-17-006306

Insider Transaction Report

Form 4
Period: 2017-06-07
KRAUSS MARLENE
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2017-06-07$10.00/sh+350,000$3,500,0003,225,000 total
Transactions
  • Purchase

    Common Stock

    2017-06-07$10.00/sh+350,000$3,500,0003,225,000 total
Footnotes (3)
  • [F1]These shares are underlying units (each unit consisting of one share of common stock, one right entitling the holder thereof to receive one-tenth (1/10) of one share of common stock upon the consummation of an initial business combination and one warrant to purchase one-half of one share of common stock) held by KBL IV Sponsor LLC (the "Sponsor"), acquired pursuant to a third amended and restated unit purchase agreement by and between the Sponsor and the issuer.
  • [F2]Each of the issuer's officers and directors is a member of the Sponsor. Dr. Marlene Krauss, the issuer's Chief Executive Officer, is the sole managing member of the Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by the Sponsor and has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by the Sponsor in which she does not have a pecuniary interest.
  • [F3]Includes up to 375,000 shares of common stock that are subject to forfeiture in the event that the underwriters of the issuer's initial public offering do not exercise their over-allotment option in full.

Issuer

KBL MERGER CORP. IV

CIK 0001690080

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001690080

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:00 PM ET
Size
7.5 KB